Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/146818 
Authors: 
Year of Publication: 
2014
Citation: 
[Journal:] Journal of Innovation and Entrepreneurship [ISSN:] 2192-5372 [Volume:] 3 [Publisher:] Springer [Place:] Heidelberg [Year:] 2014 [Pages:] 1-20
Publisher: 
Springer, Heidelberg
Abstract: 
A business model describes the design of the value creation and capture mechanisms needed to yield profit. We contend that for a business model to be viable in turbulent and hypercompetitive environments, its dynamics are important and must leverage, out of all key business model modules proposed in different studies, on a combined value and network perspective. These different elements present, however, distinctive challenges for small innovative companies and larger firms. Moreover, the business model of small firms is sited in the business models of their partners, big companies in particular. The purpose of this article is to highlight the importance of a dynamic network perspective and to understand how the networked business models in action of large firms may affect small innovative companies. We examine here the networked business models of big pharmaceutical companies and venture capital firms which interact in open innovation with small biotech companies.
Subjects: 
Open business models
Network dynamics
Strategy
Dependency
Innovation
Small business
Large firms
Value
Interdependency
JEL: 
L26
L1
L53
Persistent Identifier of the first edition: 
Creative Commons License: 
cc-by Logo
Document Type: 
Article

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.